Catalog11 refs
VIP
Immune ModulationtherapeuticImmuneResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
CirculationMuscles
Overview
Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide belonging to the glucagon/secretin superfamily. It is produced in many tissues including the gut, pancreas, and brain. VIP has potent vasodilatory, anti-inflammatory, and immunomodulatory effects. It binds to VPAC1 and VPAC2 receptors, triggering cAMP-mediated signaling cascades. Research shows therapeutic potential for pulmonary hypertension, diabetes, neurological disorders, and autoimmune conditions.
Primary Uses
Anti-inflammatory
Autoimmune conditions
Neurodegenerative conditions
Neuroprotection
Circadian rhythm regulation
Gut motility and secretion regulation
Intestinal barrier function
Mucosal immunity
Inflammatory conditions
Autoimmune diseases
Neurodegenerative disorders
Chronic inflammatory response syndrome (CIRS)
Mold illness
Pulmonary issues
Gut-brain axis signaling
Bronchodilation and vasodilation research
Immune modulation
Gut-lung axis studies
Neuropeptide signaling
Pulmonary hypertension
Vasodilation
Cardiac support
Autism spectrum disorders
Diabetes support
Sarcoidosis
Smooth muscle relaxation
Intestinal secretion
Pancreatic secretion
CIRS/mold illness
COVID-19 respiratory failure
pulmonary conditions
rheumatoid arthritis
pulmonary arterial hypertension
Protocol Reference
Dose
50 mcg
Frequency
Up to 2x daily (SubQ); or split 2-3 doses daily (intranasal)
Half-life
Very Short In Circulation, Often Only Minutes
Route
Intranasal · Subcutaneous
Evidence
Phase 3 / Extensively Studied / Clinical Trials (disputed)
Research References· 16
Research Models
CatDogHumanPorcine
Also in Immune Modulation